For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
X4 Pharmaceuticals Inc (NASDAQ: XFOR) closed the day trading at $1.26 up 5.00% from the previous closing price of $1.20. In other words, the price has increased by $5.00 from its previous closing price. On the day, 3.05 million shares were traded. XFOR stock price reached its highest trading level at $1.305 during the session, while it also had its lowest trading level at $1.1799.
Ratios:
For a better understanding of XFOR, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.34 and its Current Ratio is at 5.34. In the meantime, Its Debt-to-Equity ratio is 1.14 whereas as Long-Term Debt/Eq ratio is at 1.12.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, B. Riley Securities on December 12, 2023, Downgraded its rating to Neutral and sets its target price to $1 from $3 previously.
On December 22, 2022, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $3.Cantor Fitzgerald initiated its Overweight rating on December 22, 2022, with a $3 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 11 ’24 when Mostafa Adam S. sold 52,500 shares for $0.88 per share. The transaction valued at 46,347 led to the insider holds 0 shares of the business.
Ragan Paula sold 49,678 shares of XFOR for $43,856 on Mar 11 ’24. The President and CEO now owns 765,068 shares after completing the transaction at $0.88 per share. On Mar 11 ’24, another insider, DiBiase Mary, who serves as the Chief Operating Officer of the company, sold 15,409 shares for $0.88 each. As a result, the insider received 13,591 and left with 291,752 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, XFOR now has a Market Capitalization of 211601872 and an Enterprise Value of 155666608.
Stock Price History:
Over the past 52 weeks, XFOR has reached a high of $2.58, while it has fallen to a 52-week low of $0.57. The 50-Day Moving Average of the stock is 15.04%, while the 200-Day Moving Average is calculated to be 16.80%.
Shares Statistics:
Over the past 3-months, XFOR traded about 2.32M shares per day on average, while over the past 10 days, XFOR traded about 2806820 shares per day. A total of 167.43M shares are outstanding, with a floating share count of 122.08M. Insiders hold about 27.30% of the company’s shares, while institutions hold 35.96% stake in the company. Shares short for XFOR as of 1711584000 were 12333789 with a Short Ratio of 5.31, compared to 1709164800 on 14395571. Therefore, it implies a Short% of Shares Outstanding of 12333789 and a Short% of Float of 7.359999999999999.
Earnings Estimates
The market rating for X4 Pharmaceuticals Inc (XFOR) is a result of the insights provided by X4 Pharmaceuticals, Inc. analysts actively involved in the assessment.The consensus estimate for the next quarter is $31.61, with high estimates of $63.77 and low estimates of $57.47.
